Model G20 2027 at FLAME University — registrations now open
← Back to paper

One Young India Press · The OYI Review

Echoes in the Fog -- Understanding Dementia and Alzheimer’s

By Raghavi Choudhary - PM Shri Kendriya Vidhyalaya No 1 Gandhi Nagar, Jammu

Published 14 October 2025

Echoes in the Fog (Holding on to What Remains): Understanding Dementia and Alzheimer’s

By Raghavi Choudhary - PM Shri Kendriya Vidhyalaya No 1 Gandhi Nagar, Jammu

Abstract

Dementia, a progressive neurodegenerative condition, is characterized by the gradual erosion of memory, cognitive function, and independence, affecting more than 55 million people worldwide. There are over 400 different types of dementia, but the most common forms include Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia. This white paper explores how these conditions develop, how they impact the brain and behavior, and what key symptoms individuals and their families should look for. It also discusses the diagnostic process and the various methods for slowing dementia's progression, including medication, lifestyle modifications, and supportive care. Finally, this paper looks ahead to the future of dementia research, highlighting the potential for earlier detection through simple blood tests, the application of artificial intelligence (AI) in diagnosis, and the development of new treatments that may one day alter the course of the disease. The goal is to build a clearer understanding of dementia and offer hope for better prevention, care, and quality of life for all affected.

Introduction

Dementia is a broad term for a range of neurodegenerative disorders characterized by a progressive decline in cognitive functioning, affecting memory, thinking, and the ability to perform daily activities. Rising fastest in low- and middle-income countries, it now affects an estimated 55 million people worldwide, with nearly 10 million new cases diagnosed annually.

Alzheimer’s disease, the most common type of dementia, accounts for 60–70% of all cases. Despite extensive research, no definitive cure currently exists. However, significant advances in early detection methods and new therapies targeting the underlying protein pathologies—amyloid and tau—offer hope for slowing disease progression. This white paper aims to provide a comprehensive overview of this challenging condition, from its underlying causes to the future of its treatment.

Types of Dementia and Their Causes

While age (over 65 years) and genetics (such as the APOE ε4 allele and familial mutations) are major risk factors, dementia is often influenced by a combination of factors. Hearing loss, hypertension, diabetes, obesity, smoking, physical inactivity, depression, social isolation, air pollution, head injuries, and alcohol misuse collectively contribute significantly to the risk. Beyond these general causes, the major types of dementia have specific underlying pathologies.

1. Alzheimer’s Disease

Alzheimer’s disease, the most common type, accounts for 60-70% of cases. Its primary cause is the buildup of two abnormal proteins in the brain: amyloid plaques and tau tangles.

Together, amyloid plaques and tau tangles cause synaptic dysfunction, neuron death, and brain atrophy (shrinkage), especially in regions critical for memory and thinking. Amyloid plaques jam the communication lines between brain cells, while tau tangles cause the cell’s internal structure to collapse. This dual assault chokes and kills neurons, leading to the progressive and irreversible cognitive decline known as Alzheimer’s disease.

2. Vascular Dementia

As the second most common type of dementia, vascular dementia is caused by reduced blood flow to the brain. This can result from major strokes, a series of mini-strokes (Transient Ischemic Attacks), or chronic damage to small blood vessels.

These vascular events lead to dementia that often has a stepwise progression, with abilities declining in noticeable stages.

3. Lewy Body Dementia

This form of dementia is caused by abnormal deposits of a protein called alpha-synuclein, known as Lewy bodies, inside brain cells. Normally, alpha-synuclein helps regulate neurotransmitters at synapses, but in this disease, the protein misfolds, clumps together, and becomes toxic. Lewy bodies accumulate in the thinking, movement, and memory centers of the brain, interfering with synaptic function and causing neurons to communicate improperly. This disruption is why symptoms can fluctuate, leading to periods of clarity followed by confusion. As Lewy bodies accumulate, they trigger oxidative stress, mitochondrial dysfunction, and inflammation, ultimately killing neurons and damaging key brain regions, including the Cerebral cortex (memory, reasoning, hallucinations), Basal ganglia (movement control), and Brainstem (sleep regulation, autonomic functions like blood pressure and digestion). Lewy bodies act like toxic roadblocks inside neurons, jamming communication, damaging vital neurotransmitter systems, and ultimately causing the unique combination of cognitive, motor, and behavioral symptoms seen in Lewy body dementia.

4. Frontotemporal Dementia (FTD)

Caused by the degeneration of the frontal and temporal lobes of the brain, FTD generally affects younger people, with onset typically between 45 and 65 years of age.

In this condition, brain cells in the frontal lobes (behind the forehead) and temporal lobes (near the ears) degenerate and shrink (atrophy). Abnormal proteins, such as tau or TDP-43, often misfold and build up, damaging these neurons.

As widespread brain shrinkage occurs, it leads to severe cognitive impairment and memory loss, though memory may be spared in the early stages. Together, these degenerative processes can strip away the very essence of a person's personality, communication abilities, and social functioning.

Symptoms of Different Types of Dementia

While general symptoms like memory loss, confusion, disorientation, reduced concentration, impaired judgment, hallucinations, and physical decline are common across dementias, each type has a distinct profile. The table below provides a more in-depth comparison.

SYMPTOM AREA

Alzheimer’s Disease

Vascular Dementia

Lewy Body Dementia

Frontotemporal Dementia (FTD)

ONSET

Gradual, slow progression

Sudden or stepwise (often after strokes)

Gradual, but with significant fluctuations

Gradual, often earlier onset (before age 65)

MEMORY LOSS

Very prominent, especially for recent events

Mild to moderate

Mild initially

Usually mild in early stages

ATTENTION & CONCENTRATION

Mildly affected early, worsens over time

Markedly affected early

Fluctuates significantly from day to day

Usually preserved early on

LANGUAGE PROBLEMS

Word-finding difficulty

Sometimes present, depending on stroke location

Mild

Prominent (difficulty speaking or understanding language)

REASONING & JUDGMENT

Declines gradually

Poor due to vascular damage

Variable

Poor, often leading to risky or impulsive behavior

HALLUCINATIONS / DELUSIONS

Possible in later stages

Rare

Common and often vivid (visual)

Rare, especially early

MOVEMENT PROBLEMS

Typically appear in late stages

Possible if strokes affect motor areas

Common early signs (rigidity, tremor, shuffling)

Rare early on

PERSONALITY & BEHAVIOR

Personality changes occur in later stages

Often associated with emotional instability or apathy

Anxiety, depression, and apathy are common

Early and major personality/behavior changes are a hallmark

OTHER KEY FEATURES

Disorientation, getting lost

May have physical stroke symptoms (weakness, paralysis)

REM sleep behavior disorder, visuospatial problems

Compulsive or socially inappropriate behavior

Diagnosis

Diagnosing dementia is a multi-step process aimed at identifying cognitive decline and determining its specific cause.

Step

Diagnostic Method

What It Checks / Reveals

Helps Identify

1

Symptom Recognition

Memory loss, confusion, disorientation, behavior/language changes, difficulty with daily tasks

All types (serves as an early warning sign).

2

Medical History & Interviews

Onset, pattern, and progression of symptoms; family history; other medical conditions.

All types (helps distinguish between gradual vs. sudden onset).

3

Physical & Neurological Exam

Reflexes, balance, coordination, motor strength, vision, and hearing.

Vascular dementia (stroke signs), Lewy body dementia (motor signs).

4

Cognitive Testing (MMSE, MoCA)

Memory, attention, problem-solving, language, and visuospatial skills.

Alzheimer’s (memory decline), Lewy body (fluctuations), FTD (behavior/language deficits).

5

Blood Tests / Lab Work

Thyroid function, vitamin B12 levels, infections, electrolytes, liver/kidney function.

Rules out reversible causes of cognitive impairment (not a specific type of dementia).

6

Brain Imaging (MRI/CT)

Brain shrinkage (atrophy), white matter damage, strokes, or tumors.

Alzheimer’s (hippocampal shrinkage), Vascular (stroke lesions), FTD (frontal/temporal lobe shrinkage).

7

PET Scan

Brain activity patterns and the presence of amyloid plaques.

Alzheimer’s (amyloid deposits), Lewy body dementia (reduced occipital lobe activity).

8

CSF (Spinal Fluid) Analysis

Presence and levels of amyloid and tau proteins in the cerebrospinal fluid.

Alzheimer’s (confirms biomarker presence).

9

Genetic Testing

Specific gene mutations (if there is a strong family history or very early onset).

FTD (some inherited forms), early-onset Alzheimer’s.

10

Sleep Studies / EEG

REM sleep behavior disorder or seizure activity.

Lewy body dementia (REM sleep disorder is a key indicator), helps rule out seizures as a cause of symptoms.

11

Diagnosis Confirmation

Confirms that symptoms are progressive, persistent, and interfere with daily life.

Final step to determine the specific type of dementia based on all gathered evidence.

Management, Prevention, and Slowing Progression

Dementia currently cannot be fully cured or reversed. However, its progression can be managed and slowed, and its effects can be mitigated, especially with early detection and intervention.

1. Treat Underlying / Reversible Causes

Some conditions mimic dementia symptoms and are reversible if treated promptly. These include:

2. Slow Progression of Irreversible Dementias

While there is no cure for progressive dementias, certain medications can help slow cognitive decline and ease symptoms.

3. Cognitive & Lifestyle Interventions

A proactive approach to lifestyle can help protect remaining brain cells and enhance brain plasticity. Key interventions include:

4. Mental Health & Behavior Management

Managing mental and emotional health is crucial for overall well-being and can help prevent dementia from worsening.

The Future of Dementia Research

Research into dementia and its prevention is a dynamic and ongoing field. Several promising approaches are expected to shape the future of diagnosis and care:

These approaches, while some are still experimental, show great promise for a future with true disease-modifying treatments and more effective, compassionate care.

Conclusion

Dementia remains one of the greatest challenges to global health—a condition that not only erodes memory and cognition but also deeply impacts identity, independence, and relationships. While a complete cure still eludes us, science has made remarkable strides in understanding its causes, improving diagnosis, and developing strategies to slow its progression. Early detection, lifestyle interventions, and compassionate, supportive care can significantly improve quality of life for those affected. Meanwhile, ongoing research into disease-modifying treatments, new biomarkers, and AI-powered tools holds immense promise for transforming the future of dementia care. Ultimately, understanding dementia is not just a medical necessity but also a profound social responsibility. By increasing awareness, reducing stigma, supporting caregivers, and advancing research, we can build a future where those living with dementia are not defined by their disease but are supported to live meaningful, dignified lives.

Bibliography

General Overview of Dementia

Specific Types of Dementia

Alzheimer’s Disease

Vascular Dementia

Lewy Body Dementia

Frontotemporal Dementia

Diagnosis and Assessment

Treatment and Management

Future Directions and Research